Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013411" target="_blank" >RIV/00023736:_____/22:00013411 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1002/ajh.26627" target="_blank" >https://doi.org/10.1002/ajh.26627</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ajh.26627" target="_blank" >10.1002/ajh.26627</a>

Result language
angličtina
Original language name
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age
Original language description
In this European Society for Blood and Marrow Transplantation retrospective study, we analyzed the impact of stem cell source on leukemia-free survival (LFS) in adult patients with primary refractory or relapsed acute myeloid leukemia (AML) given grafts from HLA-haploidentical donors with PTCy as graft-versus-host disease (GVHD) prophylaxis.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)